Diminishing calcifications as a potential predictor of pancreatic ductal adenocarcinoma arising in association with IPMN in patients with chronic pancreatitis by Mohammad Yasrab, MD, Ryan C. Rizk, MS, Felipe Lopez-Ramirez, MD, Taha M. Ahmed, MD, Alejandra Blanco, MD, Ammar A. Javed, MD, Linda C. Chu, MD, Elliot K. Fishman, MD, Satomi Kawamoto, MD

Get full text

Clinicopathological features and surgical outcomes of resected functional pancreatic neuroendocrine tumors: a single institution experience by Ammar A. Javed, MD, Alina Hasanain, MD, Aleezay Haider, George Jones, BS, Zunaira N. Javed, Kevin Soares, MD, Richard A. Burkhart, MD, John L. Cameron, MD, FACS, Matthew J. Weiss, MD, FACS, Christopher L. Wolfgang, MD, PhD, FACS, Jin He, MD, PhD, FACS

Get full text

Response to Commentary on ‘“Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multi... by Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)

Get full text

Response to Commentary “Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?” by Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)

Get full text